Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Larmour

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Australian and New Zealand Journal of Medicine|June 1, 1991
Intermittent subcutaneous apomorphine injection treatment for parkinsonian motor oscillationsP A Kempster, R Iansek, I Larmour
Internal Medicine Journal|January 13, 2015
Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearanceA K H Lim, G Mathanasenarajah, I Larmour
British Journal of Clinical Pharmacology|May 1, 1985
Enalapril (MK421) activation in man: importance of liver statusI Larmour, B Jackson, R Cubela, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 24, 2015
A Review of Current Animal Models for the Study of Cervical Dysplasia and Cervical CarcinomaLuke I Larmour, Tom W Jobling, Caroline E Gargett
Journal of Cardiovascular Pharmacology|January 1, 1986
Evaluation of angiotensin converting enzyme (ACE) in the pharmacokinetics and pharmacodynamics of ACE inhibitorsC I Johnston, B Jackson, R Cubela, et al.
British Journal of Clinical Pharmacology|January 1, 1984
Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertensionC I Johnston, B J Jackson, I Larmour, et al.
Plos One|October 27, 2018
A patient derived xenograft model of cervical cancer and cervical dysplasiaLuke I Larmour, Fiona L Cousins, Julie A Teague, et al.
Chemotherapy|July 30, 2004
Chemotherapy delays progression of motor neuron disease in the SOD1 G93A transgenic mouseK M Bruce, K Narayan, H C Kong, et al.
Bone|January 24, 2016
Deferasirox at therapeutic doses is associated with dose-dependent hypercalciuriaPhillip Wong, Kevan Polkinghorne, Peter G Kerr, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Australian and New Zealand Journal of Medicine|June 1, 1991
Intermittent subcutaneous apomorphine injection treatment for parkinsonian motor oscillationsP A Kempster, R Iansek, I Larmour
Internal Medicine Journal|January 13, 2015
Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearanceA K H Lim, G Mathanasenarajah, I Larmour
British Journal of Clinical Pharmacology|May 1, 1985
Enalapril (MK421) activation in man: importance of liver statusI Larmour, B Jackson, R Cubela, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 24, 2015
A Review of Current Animal Models for the Study of Cervical Dysplasia and Cervical CarcinomaLuke I Larmour, Tom W Jobling, Caroline E Gargett
Journal of Cardiovascular Pharmacology|January 1, 1986
Evaluation of angiotensin converting enzyme (ACE) in the pharmacokinetics and pharmacodynamics of ACE inhibitorsC I Johnston, B Jackson, R Cubela, et al.
British Journal of Clinical Pharmacology|January 1, 1984
Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertensionC I Johnston, B J Jackson, I Larmour, et al.
Plos One|October 27, 2018
A patient derived xenograft model of cervical cancer and cervical dysplasiaLuke I Larmour, Fiona L Cousins, Julie A Teague, et al.
Chemotherapy|July 30, 2004
Chemotherapy delays progression of motor neuron disease in the SOD1 G93A transgenic mouseK M Bruce, K Narayan, H C Kong, et al.
Bone|January 24, 2016
Deferasirox at therapeutic doses is associated with dose-dependent hypercalciuriaPhillip Wong, Kevan Polkinghorne, Peter G Kerr, et al.
Pageof 1